Pharmaceutical Discount Agreements for Active Ingredient Dupilumab (ATC D11AH05) in Open House Model

Pharmaceutical discount agreements for the active ingredient Dupilumab (ATC D11AH05) in an Open House model: non-exclusive contracts with pharmaceutical companies under uniform conditions. Maximum duration 24 months, earliest contract start 01.09.2026, all contracts end no later than 24 months after the earliest contract start. Accession possible monthly on the first of each month within the 24-month period. Termination right 6 weeks to month-end. AOK Rheinland-Pfalz/Saarland reserves the right to replace Open House contracts with exclusive discount agreements, which automatically terminate the Open House contracts. Contract documents must be submitted electronically with a qualified signature (email to am_vertraege@rps.aok.de) or in duplicate written form (scan to email first, then original to AOK Rheinland-Pfalz/Saarland, Strategisches Vertragsmanagement Arzneimittel, Virchowstraße 30, 67304 Eisenberg). Access to documents via www.dtvp.de after registration and activation. Communication exclusively via email. Only pharmaceutical companies are eligible as contractors, confidentiality of documents required. Deadline for contract start 01.09.2026 is 31.07.2026; for later monthly starts, documents must be received by the end of the month preceding the desired contract start month. This publication serves transparency and does not constitute a public procurement within the meaning of Directive 2014/24/EU.

Tender documents

Additional details